The Population Screening Global Market Report 2023, provides comprehensive information on the population screening market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Population Screening Market’s Growth:
As per The Business Research Company’s Population Screening Global Market Report 2023, the global population screening market is expected to grow from $25.04 billion in 2022 to $27.02 billion in 2023 at a compound annual growth rate (CAGR) of 7.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The population screening market is expected to reach $35.37 billion in 2027 at a CAGR of 7%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
Technological advancements are the key trend gaining popularity in the population screening market. Major companies operating in the population screening market are adopting new technologies to sustain their position in the market. For instance, in May 2021, Evoq Technologies LLC, a US-based company developing innovative technologies for healthcare and biotechnology research, launched SmartERG, the first phone-based retinal health testing platform. This device works to gather data about retinal health by flashing a regulated light at the eye and collecting an electrical and physiological response from the retina. Based on a delay or reduction in visual responses, it can identify retinal diseases that may develop to cause vision loss or blindness. It provides cloud services with strong AI (artificial intelligence) and machine learning support, easy patient-provider linkages, and ophthalmic care.
The population screening market is segmented:
1) By Product: Hardware Equipment, Testing Or Lab, Analytics Or Interpretation
2) By Gender: Male, Female
3) By Age: Ages Less Than 15, 15-65, Ages 65 And Above
4) By Business: Hospitals, Research Institutes, Diagnostic Labs
North America was the largest region in the population screening market in 2022.
The table of contents in TBRC’s population screening market report includes:
- Executive Summary
- Population Screening Market Characteristics
- Population Screening Market Trends And Strategies
- Population Screening Market – Macro Economic Scenario
- Global Population Screening Market Size and Growth
- Global Population Screening Market Competitive Benchmarking
- Global Population Screening Market Competitive Dashboard
- Key Mergers And Acquisitions In The Population Screening Market
- Population Screening Market Future Outlook and Potential Analysis
Top 5 Major Key Players Are:
- Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc
- Abbott Laboratories
- Siemens Healthineers AG
- Quest Diagnostics Incorporated
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model